News Releases

A New Strategy for Making Blood Stem Cells Healthier
Two Prominent Researchers Take Helm of Psychiatric Research Institute at Montefiore Einstein
Two Nature Papers Highlight an Understudied Protein

Facts & Stats

Published Papers
NIH Research Funding
Students
Full-time Faculty
Global Initiatives
Clinical and Research Centers
Alumni

Expert List for Media

Richard B. Lipton

Richard B. Lipton, M.D.

Area(s) of expertise: HeadacheAgingAlzheimer's disease/dementia

A noted authority on headaches and migraine, Dr. Lipton is director of the Montefiore Headache Center, recognized internationally for its leadership in the diagnosis, classification and treatment of headache disorders. Dr. Lipton is… Learn more

Einstein in the News


ABC 7 NY
NYC Invests $38M into New Biotech Centers

Montefiore and Einstein will receive $13 million from New York City as part of its investment in new biotech centers. The Einstein-Montefiore Biotechnology Accelerated Research Center (EMBARC) will establish a biomanufacturing operation focused on cell, gene, and antibody therapy production and will provide scientific facilities to early-stage and established companies.

Additional Coverage includes AMNY, New York Business Journal, Connect New York, Patch.com, Yahoo News, and WPIX11

The Scientist
What's Ahead for SARS-CoV-2 Research in 2021

Kartik Chandran, Ph.D., talks about the future of COVID-19 research, including the development of treatments and vaccines to treat and prevent the novel coronavirus as it mutates over time. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.

More coverage on Dr. Chandran

The New York Times
Blood Plasma Reduces Risk of Severe Covid-19 if Given Early

Liise-anne Pirofski, M.D., discusses a small Argentinian clinical trial that found convalescent plasma was effective in reducing the risk of severe COVID-19 in older patients if they received the treatment within three days of showing symptoms. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.

More coverage on Dr. Pirofski

Multimedia

When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog